Skip to content

Discontinued — last reported Q4 '25

CapEx at other companies

Eli Lilly logo
Eli LillyLLY
$2.33B+54.0%
Pfizer logo
PfizerPFE
$436M-22.7%
Merck & Co. logo
Merck & Co.MRK
$991M-25.4%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$133.4M+228%
Cytokinetics logo
CytokineticsCYTK
$5.93M+4.7%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$35K-64.6%

Other financials

Income statement

See full
Revenue$21.1M+1,572%
Gross profit$21.0M+1,604%
Operating income-$996.0K+96.1%
Net income-$1.0M+95.9%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$67.1M+6.7%
Total debt$57.7M-45.7%
Total equity$202.9M+64.9%
Total assets$268.8M-9.7%

Cash flow

See full
Operating cash flow-$14.7M+66.4%
Free cash flow-$17.2M+21.5%

Valuation

See full
Market cap$986.12M+262%
Enterprise value$976.73M+209%
P/S14.2×+5.4×

Profitability

See full
Gross margin99.5%+1.5pp
Operating margin-34.8%-16.8pp
Net margin-37.5%-18.1pp
FCF margin-578.5%-283pp

Returns & leverage

See full
Return on equity-16%-7.2pp
Debt / equity0.3×-0.6×
Current ratio18.8×+16.6×

Where this comes from

Reported directly by Lexicon Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Lexicon Pharmaceuticals’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lexicon Pharmaceuticals's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lexicon Pharmaceuticals's capex?
Lexicon Pharmaceuticals (LXRX) reported capex of $0 in Q4 2025.
How has Lexicon Pharmaceuticals's capex changed year-over-year?
Lexicon Pharmaceuticals's capex decreased by 100.0% year-over-year, from $474K to $0.
What is the long-term trend for Lexicon Pharmaceuticals's capex?
Over 3 years (2021 to 2024), Lexicon Pharmaceuticals's capex has grown at a -5.5% compound annual growth rate (CAGR), from $1.22M to $1.03M.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.